What kind of company does Teva wish to be? Where will it direct its capital, amid the constraints imposed by the continued necessity that it services its massive debt load? Fundamentally, how does the company plan to return to growth after years of stagnation?
These questions are set to be addressed during an Investor Day the Israeli firm has scheduled for Thursday 18 May,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?